Skip to main content
logo
Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.8017
-0.0293 (-3.53%)
At close: Aug 20, 2026, 4:00 PM EDT
0.7813
-0.0204 (-2.54%)
After-hours: Aug 20, 2026, 6:15 PM EDT

Oncolytics Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
20.315.4110.112.188.4910.52
Research & Development
17.4113.3115.4413.4111.410.21
Operating Expenses
37.7128.7325.5425.5919.8920.73
Operating Income
-37.71-28.73-25.54-25.59-19.89-20.73
Interest & Investment Income
0.250.390.9810.390.08
Currency Exchange Gain (Loss)
0.13-0.110.7-0.361.23-0.11
Other Non Operating Income (Expenses)
--0.241.174-0.010.01
EBT Excluding Unusual Items
-37.34-28.68-22.7-20.94-18.29-20.75
Pretax Income
-37.34-28.68-22.7-20.94-18.29-20.75
Income Tax Expense
0.120.080.10.070.060.04
Net Income
-37.46-28.76-22.79-21.01-18.35-20.79
Net Income to Common
-37.46-28.76-22.79-21.01-18.35-20.79
Net Income Growth
------
Shares Outstanding (Basic)
1109676685854
Shares Outstanding (Diluted)
1109676685854
Shares Change
33.18%25.33%13.10%16.53%8.44%32.66%
EPS (Basic)
-0.34-0.30-0.30-0.31-0.32-0.39
EPS (Diluted)
-0.34-0.30-0.30-0.31-0.32-0.39
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-26.72-20.12-20.06-21.55-17.3-17.95
Free Cash Flow Per Share
-0.24-0.21-0.26-0.32-0.30-0.34
EBITDA
-37.65-28.66-25.46-25.53-19.82-20.63
D&A For EBITDA
0.060.070.090.060.070.1
EBIT
-37.71-28.73-25.54-25.59-19.89-20.73
SEC Filings: 10-K · 10-Q